Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
Open Access
- 27 January 1999
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 60 (2) , 94-98
- https://doi.org/10.1002/(sici)1096-8652(199902)60:2<94::aid-ajh2>3.0.co;2-a
Abstract
To evaluate that the relationship between the truncated form of tissue factor pathway inhibitor (TFPI) and the stage of disseminated intravascular coagulation (DIC), we measured the plasma levels of tissue factor (TF) antigen and the intact and truncated forms of TFPI antigens in 41 patients with DIC, 12 with pre‐DIC, and 20 with non‐DIC. The plasma TF and total TFPI antigen levels were significantly higher in patients with DIC than in non‐DIC patients. Plasma levels of intact TFPI antigen in the pre‐DIC groups were significantly lower than in the non‐DIC and DIC groups. The truncated form of TFPI antigen levels in DIC patients were significantly increased compared with those in non‐DIC and pre‐DIC patients. The fact that the intact form of TFPI was decreased in pre‐DIC patients compared with that in non‐DIC patients, suggests that it is consumed in the pre‐DIC state and that hypercoagulability occurs in pre‐DIC patients. The increased level of the truncated form of TFPI in DIC patients may be attributed to proteolysis of the intact form of TFPI in these patients. The increased level of the truncated form of TFPI may be a useful index for the diagnosis of DIC. Am. J. Hematol. 60:94–98, 1999.Keywords
This publication has 29 references indexed in Scilit:
- Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulationAmerican Journal of Hematology, 1996
- Effect of Heparin on the Inhibition of Factor Xa by Tissue Factor Pathway Inhibitor: A Segment, Gly212-Phe243, of the Third Kunitz Domain Is a Heparin-Binding SiteBiochemistry, 1995
- Tissue Factor Pathway InhibitorThrombosis and Haemostasis, 1995
- Tissue factor pathway inhibitor in infants and childrenThrombosis Research, 1994
- Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulationAmerican Journal of Hematology, 1992
- Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.Proceedings of the National Academy of Sciences, 1990
- The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide a in systemic meningococcal diseaseThrombosis Research, 1989
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Pathophysiologic and Biochemical Events in Disseminated Intravascular Coagulation: Dysregulation of Procoagulant and Anticoagulant PathwaysSeminars in Thrombosis and Hemostasis, 1989
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of actionBlood, 1988